Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
elbasvir (1 trial)
grazoprevir (zepatier) (1 trial)
Fibrosis (Phase 3)
Hepatitis C (Phase 3)
Trials (1 total)
Trial APIs (2 total)